We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
-5.17%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
AUM
$1.2B
AUM Growth
-$254M
Cap. Flow
-$168M
Cap. Flow %
-13.91%
Top 10 Hldgs %
33.46%
Holding
60
New
6
Increased
2
Reduced
37
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 26.49%
2 Communication Services 11.76%
3 Industrials 10.83%
4 Utilities 10.29%
5 Energy 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCI icon
26
Johnson Controls International
JCI
$92.6B
$29.4M 2.44%
677,797
-203,940
-23% -$9.4M
XOM icon
27
ExxonMobil
XOM
$657B
$29.1M 2.41%
391,195
-33,480
-8% -$2.58M
CVX icon
28
Chevron
CVX
$386B
$27.5M 2.28%
348,662
+300
+0.1% +$25.3K
TMO icon
29
Thermo Fisher Scientific
TMO
$223B
$25.3M 2.1%
206,614
-27,745
-12% -$3.61M
EOG icon
30
EOG Resources
EOG
$75.1B
$24.9M 2.06%
341,383
-72,028
-17% -$5.6M
CELG
31
DELISTED
Celgene Corp
CELG
$24.8M 2.06%
229,114
-41,110
-15% -$5.1M
JNJ icon
32
Johnson & Johnson
JNJ
$629B
$24M 1.99%
256,816
-30,490
-11% -$2.95M
ABT icon
33
Abbott
ABT
$192B
$23.8M 1.98%
591,657
-79,968
-12% -$3.77M
AMGN icon
34
Amgen
AMGN
$225B
$23.7M 1.97%
171,368
-23,350
-12% -$3.68M
MDLZ icon
35
Mondelez International
MDLZ
$79.4B
$5.05M 0.42%
120,550
-21,800
-15% -$939K
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$4.49M 0.37%
75,900
-11,100
-13% -$704K
ADP icon
37
Automatic Data Processing
ADP
$107B
$1.78M 0.15%
22,150
-300
-1% -$24K
KHC icon
38
Kraft Heinz
KHC
$29.1B
$1.75M 0.15%
+24,800
New +$1.87M
FE icon
39
FirstEnergy
FE
$27.2B
$1.51M 0.13%
48,400
UNP icon
40
Union Pacific
UNP
$174B
$1.28M 0.11%
14,500
+2,000
+16% +$183K
BAX icon
41
Baxter International
BAX
$13.9B
$1.2M 0.1%
+36,400
New +$1.38M
CL icon
42
Colgate-Palmolive
CL
$73.6B
$1.08M 0.09%
17,000
-100
-0.6% -$6.53K
IFF icon
43
International Flavors & Fragrances
IFF
$21.4B
$991K 0.08%
9,600
A icon
44
Agilent Technologies
A
$41.9B
$989K 0.08%
28,800
BRK.B icon
45
Berkshire Hathaway Class B
BRK.B
$1.09T
$978K 0.08%
7,500
SO icon
46
Southern Company
SO
$106B
$903K 0.08%
20,200
-1,053,749
-98% -$46.2M
ZBH icon
47
Zimmer Biomet
ZBH
$18.7B
$878K 0.07%
9,631
GILD icon
48
Gilead Sciences
GILD
$168B
$815K 0.07%
8,300
-100
-1% -$11.1K
PEP icon
49
PepsiCo
PEP
$189B
$688K 0.06%
7,300
PG icon
50
Procter & Gamble
PG
$335B
$543K 0.05%
7,550

Similar funds

Stralem & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Stralem & Co held 60 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Stralem & Co withdrew a net $168M in Q3 2015, closing 5 positions and reducing 37 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Communication Services and Industrials.

Against the trend, Stralem & Co opened a new position in Duke Energy worth $38.1M.

  • Stralem & Co's largest Q3 2015 buy was Duke Energy: 529,450 shares worth $38.1M.
  • Stralem & Co added most to Union Pacific in Q3 2015, an estimated $183K increase.
  • Stralem & Co's biggest Q3 2015 reduction was Southern Company, cutting an estimated $46.2M.
  • Stralem & Co fully exited Alphabet (Google) Class C in Q3 2015, selling an estimated $36M.
  • Stralem & Co's ten largest holdings make up 33% of its $1.2B portfolio in Q3 2015.
  • Stralem & Co opened 6 new positions and closed 5 in Q3 2015.
  • Stralem & Co's portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Stralem & Co's 13F filing for Q3 2015, filed 15 Oct 2015.